1.
Curr Drug Targets
; 19(7): 798-804, 2018.
Artículo
en Inglés
| MEDLINE
| ID: mdl-28068895
RESUMEN
BACKGROUND: In the treatment of Inflammatory Bowel Diseases (IBD) despite advances in medical therapies, surgery has maintained a leading role in the management of complications of the disease, as well as in cases of failure of medical therapy. OBJECTIVE: discuss the possible role for a personalization in debated fields of surgical treatment of Crohn's disease and ulcerative colitis. CONCLUSIONS: Surgery has become more and more minimally invasive, struggling for a difficult balance between guidelines and personalized treatment tailored on the single patient's need. There is no room for fixed management for surgery in IBD. A tailored approach is key to better outcome in each specific patient.